PrescriptionDrugs.org

Clonidine

Brand names: Catapres, Catapres-TTS, Kapvay

Central Alpha-2 Agonists

Key Takeaway

Clonidine is a central alpha-2 adrenergic agonist used to treat high blood pressure and, in its extended-release form (Kapvay), ADHD in children and adolescents. It is also widely used off-label for opioid withdrawal, anxiety, insomnia, menopausal hot flashes, and Tourette syndrome.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

How does Clonidine work?

Your brain contains a control center for blood pressure called the vasomotor center in the brainstem [1, 2]. This center sends signals through the sympathetic nervous system that tell your heart to beat faster and your blood vessels to constrict, which raises blood pressure.

Clonidine works by stimulating alpha-2 adrenergic receptors in the brainstem [1, 3]. When these receptors are activated, they turn down the sympathetic nervous system output — essentially telling the brain to send fewer "speed up" signals to the heart and blood vessels. The result is:

- Blood vessels relax — reducing peripheral vascular resistance [1, 2] - Heart rate slows — reducing cardiac output - Blood pressure decreases — both systolic and diastolic - Norepinephrine release decreases — reducing the overall "fight-or-flight" response

Beyond blood pressure control, this dampening of the sympathetic nervous system explains clonidine's many off-label uses [4, 5]. In ADHD, clonidine reduces hyperarousal and improves attention by modulating the prefrontal cortex [4]. In opioid withdrawal, it reduces the sympathetic overdrive (sweating, anxiety, rapid heart rate) that occurs when opioids are discontinued [5]. In hot flashes, it reduces the vasomotor instability that causes flushing.

Important warning: Because clonidine works by suppressing the sympathetic nervous system, stopping it abruptly can cause rebound hypertension — a dangerous spike in blood pressure. It must always be tapered gradually [1, 2].

What to expect when starting Clonidine

When starting clonidine, the most noticeable effects are drowsiness and dry mouth [1, 2].

First 1-3 days: Sedation is common and can be significant. Many doctors recommend starting clonidine at bedtime to take advantage of the sedative effect. You may feel drowsy, have a dry mouth, and notice your blood pressure decreasing.

First 1-2 weeks: Drowsiness typically improves as your body adjusts, though dry mouth may persist. Blood pressure reduction is noticeable.

Transdermal patch: If using the Catapres-TTS patch, therapeutic blood levels take 2-3 days to develop. The patch is changed weekly. Some patients develop skin irritation at the application site — rotating sites helps [1].

For ADHD (Kapvay): Effects on attention and hyperactivity may take 2-4 weeks to fully develop. The dose is titrated slowly over several weeks.

CRITICAL — never stop abruptly [1, 2]: Stopping clonidine suddenly can cause dangerous rebound hypertension within 18-72 hours. Symptoms include rapid blood pressure rise, headache, nervousness, tremor, and rapid heartbeat. Always taper over at least 2-4 days under medical supervision.

What are the common side effects of Clonidine?

Common

Common(8 effects)
  • Dry mouth25-40%
  • Drowsiness/sedation20-35%
  • Dizziness5-16%
  • Constipation2-10%
  • Fatigue4-16%
  • Headache1-5%
  • Skin irritation (transdermal patch)15-50% of patch users
  • Nausea1-5%
Uncommon(2 effects)
  • Sexual dysfunction (erectile dysfunction, decreased libido)2-3%
  • Insomnia (paradoxical)1-4%

What are the serious side effects of Clonidine?

Serious

Common(1 effect)
  • Allergic contact dermatitis (transdermal)5-10% of patch users
Serious(3 effects)
  • Severe bradycardia<1%
  • AV blockRare
  • Severe depressionRare
Life-Threatening(1 effect)
  • Rebound hypertension (on abrupt withdrawal)Dose-dependent, higher with doses >0.3 mg/day

What drugs interact with Clonidine?

  • Major
    Beta-blockers (metoprolol, propranolol) Additive bradycardia and hypotension. If both must be discontinued, stop the beta-blocker first, then taper clonidine, to avoid rebound hypertension not opposed by beta-blockade.
  • Major
    Tricyclic antidepressants (amitriptyline, imipramine) TCAs can reduce or abolish the antihypertensive effect of clonidine by blocking alpha-2 receptors. May also worsen rebound hypertension on withdrawal.
  • Moderate
    CNS depressants (benzodiazepines, opioids, alcohol) Additive sedation, respiratory depression risk. Use with caution and monitor for excessive drowsiness.
  • Moderate
    Digoxin Additive bradycardia and AV conduction slowing. Monitor heart rate closely.
  • Moderate
    Verapamil, diltiazem Additive bradycardia and AV block risk. Use combination with caution.
  • Moderate
    Mirtazapine Mirtazapine (an alpha-2 antagonist) can reduce the antihypertensive effect of clonidine.
  • Moderate
    Prazosin, doxazosin Additive hypotension. May be beneficial therapeutically but requires dose adjustment.

View all drug interactions →

Can I eat certain foods or drink alcohol with Clonidine?

Food [1]: Clonidine can be taken with or without food. Food does not significantly affect absorption or efficacy.

Alcohol — IMPORTANT [1, 2]: Alcohol significantly enhances the sedative effects of clonidine and can cause excessive drowsiness, dizziness, and dangerously low blood pressure. Avoid alcohol or limit consumption to very small amounts, especially during the first few weeks of treatment or after dose increases. The combination can impair driving and cognitive function more than either substance alone.

Caffeine: Caffeine may partially counteract the blood pressure-lowering effect of clonidine. Moderate caffeine consumption is generally acceptable, but avoid excessive intake if blood pressure control is suboptimal.

Grapefruit: Clonidine is not metabolized by CYP3A4 and does not have a significant grapefruit interaction.

What is the typical dosage for Clonidine?

Hypertension [1, 2]: - Oral: Start 0.1 mg twice daily. May increase by 0.1 mg/day at weekly intervals. Usual range: 0.2-0.6 mg/day in divided doses. Maximum: 2.4 mg/day (rarely needed) - Transdermal (Catapres-TTS): Start TTS-1 (0.1 mg/day release), applied weekly. May increase at 1-2 week intervals. Available as TTS-1 (0.1 mg/day), TTS-2 (0.2 mg/day), TTS-3 (0.3 mg/day)

ADHD (Kapvay — extended-release) [4]: - Ages 6-17: Start 0.1 mg at bedtime. Increase by 0.1 mg/day at weekly intervals. Target: 0.1-0.2 mg twice daily. Maximum: 0.4 mg/day - Can be used alone or as adjunct to stimulants - Kapvay ER tablets should not be substituted with IR clonidine

Opioid withdrawal (off-label) [5]: - Oral: 0.1-0.3 mg every 6-8 hours. Adjust to symptom relief while avoiding excessive hypotension. Taper over 3-7 days.

Menopausal hot flashes (off-label): - 0.1-0.15 mg twice daily or TTS-1 weekly patch

CRITICAL — tapering [1, 2]: When discontinuing, reduce dose gradually over 2-4 days (or longer for higher doses). Do not stop abruptly.

How much does Clonidine cost?

Generic clonidine is widely available and very affordable [6, 7].

Pricing comparison [6, 7]: - Generic clonidine IR tablets: $4-10/month - Generic clonidine ER (Kapvay generic): $30-80/month - Brand Catapres: rarely prescribed, $100+/month - Brand Catapres-TTS patches: $150-300/month - Generic transdermal patches: $40-80/month - Clonidine IR is available on most $4 generic programs

Insurance coverage: Generic clonidine IR is Tier 1 on virtually all formularies. ER and transdermal formulations may be Tier 2-3 [7].

Cost-saving tips: - IR tablets are the most affordable option - GoodRx coupons typically bring IR tablets below $8/month - For ADHD, generic Kapvay is significantly cheaper than brand - Patient assistance programs available through various manufacturers

Is Clonidine safe during pregnancy or breastfeeding?

Pregnancy [1, 2]: Clonidine was formerly classified as FDA Pregnancy Category C. Animal studies at doses 3 times the maximum human dose showed no teratogenicity, but there are no adequate human studies [1].

Clonidine crosses the placenta and is generally not a first-line antihypertensive in pregnancy. Preferred alternatives include methyldopa, labetalol, and nifedipine. However, clonidine may be used if other options are inadequate or not tolerated.

Breastfeeding [1, 8]: Clonidine is excreted in human breast milk. Concentrations in milk are approximately twice those in maternal plasma [1]. The infant may receive a clinically significant dose, potentially causing sedation or hypotension. Clonidine is generally not recommended during breastfeeding. If used, monitor the infant for drowsiness, poor feeding, and low blood pressure.

Is there a generic version of Clonidine?

Generic clonidine has been available for decades [6, 7].

Available generic formulations: - Clonidine HCl tablets (IR): 0.1, 0.2, 0.3 mg — equivalent to Catapres - Clonidine HCl ER tablets: 0.1 mg — equivalent to Kapvay - Clonidine transdermal patches: 0.1, 0.2, 0.3 mg/day (weekly) — equivalent to Catapres-TTS - All generics are AB-rated by the FDA [6]

IR vs. ER tablets: IR clonidine is taken 2-3 times daily and is very inexpensive. ER (Kapvay) is FDA-approved for ADHD in children and is taken twice daily with a modified-release profile. They are not interchangeable.

Patch vs. oral: Patches provide constant drug delivery over 7 days, avoiding the peaks and troughs of oral dosing. This may reduce side effects but is more expensive. Patch users should have oral clonidine available as backup in case a patch falls off.

For Caregivers

Tapering education — CRITICAL [1, 2]: The most important caregiver responsibility is ensuring clonidine is never stopped abruptly. Rebound hypertension can be life-threatening. Ensure an adequate supply is always available. If the patient runs out, contact the doctor immediately.

Sedation monitoring [1]: Clonidine causes significant drowsiness, especially when starting or increasing the dose. Monitor for excessive sedation, especially in elderly patients or those taking other sedating medications. Avoid driving until the sedative effect is known.

Patch management (if applicable) [1]: The transdermal patch should be applied to a hairless area of the upper arm or chest, rotated weekly. If the patch falls off, apply a new one to a different site. Monitor for skin irritation — if allergic contact dermatitis develops, the transdermal route must be abandoned.

ADHD in children [4]: For children on Kapvay, monitor for excessive sedation (especially at school), low blood pressure, and mood changes. Missed doses are more concerning with clonidine than with stimulants due to the risk of rebound effects.

Frequently asked questions about Clonidine

References

  1. [Regulatory] Catapres (clonidine hydrochloride) FDA Prescribing Information. Boehringer Ingelheim. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017407s045lbl.pdf Accessed 2026-02-15.
  2. [Regulatory] DailyMed - Clonidine hydrochloride tablet label and package insert. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c1e949c7-4f3d-4bf2-b3a5-9b3c8f1c4e69 Accessed 2026-02-15.
  3. [Clinical] Reid JL. Clinical pharmacology of clonidine: therapeutic application in cardiovascular disease. J Cardiovasc Pharmacol. 1985;7 Suppl 8:S29-S37. https://pubmed.ncbi.nlm.nih.gov/2414574/ Accessed 2026-02-15.
  4. [Regulatory] Kapvay (clonidine hydrochloride extended-release tablets) FDA Prescribing Information. Concordia Pharmaceuticals. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022331s015lbl.pdf Accessed 2026-02-15.
  5. [Clinical] Gold MS, et al. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 1978;2(8090):599-602. https://pubmed.ncbi.nlm.nih.gov/80526/ Accessed 2026-02-15.
  6. [Regulatory] FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations — Clonidine. https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book Accessed 2026-02-15.
  7. [Regulatory] MedlinePlus: Clonidine. https://medlineplus.gov/druginfo/meds/a682243.html Accessed 2026-02-15.
  8. [Regulatory] Drugs and Lactation Database (LactMed) — Clonidine. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501169/ Accessed 2026-02-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: